<DOC>
	<DOCNO>NCT00334399</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy safety Miglitol patient Type2 Diabetes Mellitus treat Biguanide .</brief_summary>
	<brief_title>Double-Blind Trial Miglitol Type 2 Diabetic Patients Treated With Biguanide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Miglitol</mesh_term>
	<criteria>Type 2 diabetic patient treat Biguanide Criteria postprandial plasma glucose HbA1c meet Type 1 diabetes Patients treat antidiabetic drug Insulin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>alpa-glucosidase inhibitor , Biguanide</keyword>
</DOC>